Philip Weidner
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
PPARγ activation sensitizes MSS gastrointestinal cancer cells to PD1 blockage.
Journal: Cancer treatment and research communications
Published: November 10, 2025
Digestive cancers: mechanisms, therapeutics and management.
Journal: Signal transduction and targeted therapy
Published: June 29, 2024
Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
Journal: Cancer letters
Published: December 04, 2023
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 20, 2022
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.
Journal: The lancet. Healthy longevity
Published: February 28, 2022
PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells.
Journal: Oncoimmunology
Published: May 24, 2021
Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma Recurrence.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: April 21, 2021
Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma.
Journal: Oncogenesis
Published: December 03, 2019
Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.
Journal: Oncoimmunology
Published: January 28, 2019
Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: September 22, 2018
Last Updated: 09/26/2026